New User:

Forgot your password?

Stock Market & Financial Investment News

News For SYK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 22, 2014
16:36 EDTSYKOsiris enters strategic partnership with Stryker
Osiris Therapeutics (OSIR) announced that it has entered into an exclusive, worldwide partnership with Stryker (SYK) for the commercialization and development of Osirisí viable bone matrix tissue form. Stryker is a global leader in medical technology whose products and services are available in over 100 countries around the world. This partnership strategically aligns one of Osirisí regenerative medicine technologies with Strykerís innovative medical device portfolio; the resulting synergies will maximize the market potential. The Agreement provides Stryker with exclusive, worldwide rights to Osirisí viable bone matrix under the name BIO4. Osiris will be responsible for the manufacturing, continued research and product improvement activities while Stryker will be responsible for the commercialization and marketing of BIO4. To demonstrate the differentiating benefits and ensure the continued success and growth of this innovative product, both organizations will collaborate on the design and conduct of future clinical development programs.
December 19, 2014
13:34 EDTSYKStryker shares look inexpensive, should continue to rise, Barron's says
Despite rising more than 30% over the past year, shares of Stryker still have plenty of upside potential, Barron's reports. The company sports industry-leading organic sales, a strong balance sheet, and is trading at a discount to the broader medical device industry, all of which should push shares higher, Barron's adds. Reference Link
December 8, 2014
12:42 EDTSYKStryker resolves government investigation of OtisMed matter
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use